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Abstract
Objective: To estimate the cost-effectiveness of cataract surgery and refractive error/presbyopia correction in
Zambia.
Methods: Primary data on costs and health related quality of life were collected in a prospective cohort study of
170 cataract and 113 refractive error/presbyopia patients recruited from three health facilities. Six months later,
follow-up data were available from 77 and 41 patients who had received cataract surgery and spectacles,
respectively. Costs were determined from patient interviews and micro-costing at the three health facilities. Utility
values were gathered by administering the EQ-5D quality of life instrument immediately before and six months after
cataract surgery or acquiring spectacles. A probabilistic state-transition model was used to generate
cost-effectiveness estimates with uncertainty ranges.
Results: Utility values significantly improved across the patient sample after cataract surgery and acquiring
spectacles. Incremental costs per Quality Adjusted Life Years gained were US$ 259 for cataract surgery and US$ 375
for refractive error correction. The probabilities of the incremental cost-effectiveness ratios being below the Zambian
gross national income per capita were 95% for both cataract surgery and refractive error correction.
Conclusion: In spite of proven cost-effectiveness, severe health system constraints are likely to hamper scaling up
of the interventions.
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Introduction
It is estimated that 39 million people were blind and 239
million visually impaired in 2010, with cataract and un-
corrected refractive error (RE) being the leading causes
[1]. This is also the case in southern Zambia, where a
rapid assessment of avoidable blindness survey identified
cataract (47%) and uncorrected RE (20%) as the principal
causes of blindness [2]. However, a situation analysis of
Zambian eye care services in 2011 concluded that there
were major shortcomings, with lack of skilled human re-
sources, inadequate spectacles manufacturing workshops
and inequity in service provision between urban and
rural areas [3].
The “Livingstone to Lusaka Urban Comprehensive Eye
Care project” was implemented by Sightsavers between
2009–2014, with support from Standard Chartered Bank’s
“Seeing is Believing” programme [4]. The aim of the pro-
ject was to reduce blindness and ocular morbidity among
approximately two million people living between Living-
stone, in Southern Zambia, and the capital Lusaka. The
objective of the present study was to estimate the cost-
effectiveness of cataract surgery and RE/presbyopia cor-
rection delivered in three facilities supported by this
project.
Methods
Cataract surgery and correction of RE were chosen for
this evaluation because the costs and health effects can
be relatively well defined without long term follow-up.
The study took a societal perspective, including costs in-
curred by both the health sector and patients. However,
time costs of seeking care and productivity loss due to
reduced eye sight were not included. This cost was ex-
cluded partly because cataract patients are generally
older than the productive age and because of inherent
problems of valuing time in settings with a large infor-
mal sector [5].
Data were collected between March and December
2011. Patient interviews were conducted by trained inter-
viewers to collect socio-demographic data, information on
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Health Related Quality of Life (HRQOL) and out-of-
pocket costs. Questionnaires and informed consent forms
were translated and back-translated into the three main
local languages. Information about the study was provided
to participants orally in their own language. Signed
consent was obtained when possible. Those who were
illiterate provided a thumbprint. Patients were followed up
at home six months after the intervention when the
HRQOL instruments were re-administered. The cost and
HRQOL data informed a decision analytic model for esti-
mating the cost-effectiveness of cataract surgery and RE/
presbyopia correction.
Ethical approval was granted by the University of
Zambia and the London School of Hygiene & Tropical
Medicine. Data were analysed in Microsoft Excel and
STATA version 11.1.
Study health facilities
Three health facilities were included. Lusaka Eye Hospital
(LEH) is a private not-for-profit, urban tertiary facility with
40 beds, which offers advanced surgical procedures and
employs at least one ophthalmologist at any one time [6].
Livingstone (semi-urban) and Choma (rural) General Hos-
pitals are secondary level government facilities with eye
units. Livingstone General Hospital has 325 beds; ten of
which are for eye patients only. Choma General Hospital
has 157 beds and eye patients are admitted to the general
ward. Ophthalmic surgery is compromised at both these
government facilities due to lack of skilled staff. At the
time of the study, Livingstone had one ophthalmic clinical
officer, one ophthalmic nurse and a part-time ophthal-
mologist, while Choma had one ophthalmic clinical officer
and two general nurses. Surgeries in Choma were only
performed during visits by ophthalmologists or cataract
surgeons from other facilities. Services were free in the
two Government facilities if patients were referred from a
primary health facility and drugs were free if they were in
stock at the hospital pharmacies. Patients not referred had
to pay a registration fee of 30,000 Kwacha (US$ 6.34). Pa-
tients paid user fees at LEH, which covered the full costs
of the service [6].
Cataract patients were recruited before surgery and
those with RE/presbyopia were recruited immediately
after their optometrist consultation. Patients who had
the potential to benefit from spectacles according to the
clinical judgement of the optometrist were included. At
LEH and in Choma all patients were recruited at the
hospital, but in Livingstone 57% of cataract and 66% of
RE/presbyopia patients were recruited during outreach
services undertaken as part of the Sightsavers project. At
the two government hospitals, cataract patients were not
operated immediately after baseline interviews as they
had to wait for an ophthalmologist to be available.
Sample size
In a Kenyan study the self-rated health Visual Analogue
Scale (VAS) of the European Quality of Life Questionnaire
(EQ-5D) was administered before and after cataract sur-
gery [7]. Possible scores ranged from 0 (representing worst
imaginable health state) to 100 (best imaginable health
state). The mean score improved from 47.7 before surgery
to 58.0 at follow-up [7]. To observe an improvement of
the same magnitude with two-sided statistical significance
of 1% and 90% power, 53 patients would be required. This
was increased to 66 to account for 25% loss to follow-up,
and we aimed for this sample size at all facilities.
A study on HRQOL improvement from correction of
presbyopia in Zanzibar showed a 15-point difference in
the general health dimension [8]. Hence, with 1% signifi-
cance and 90% power, 17 patients per facility would be suf-
ficient to detect an impact of correction with spectacles.
The sample size was doubled to also include RE and fur-
ther increased by 25% to account for loss to follow-up.
The aim was thus to recruit 198 cataract patients and 126
RE/presbyopia patients across the three facilities.
Visual acuity and quality of life measurement
Best-corrected visual acuity (VA) in the better-seeing eye
was measured by the clinical staff at the facility using a
Snellen chart and subsequently obtained from patient re-
cords. The Snellen values were converted into logMAR,
by assigning a value of 1.85 logMAR to ‘counting fingers’
and 2.3 logMAR to vision of hand movements or less [9].
Changes in HRQOL due to cataract surgery and RE
correction were measured from a survey that allowed
for the calculation of utilities using EQ-5D [10]. This
generic HRQOL instrument has five dimensions (mobil-
ity, self-care, usual activities, pain/discomfort and anx-
iety/depression) and each dimension has three levels (no
problems, some problems or severe problems). The scale
was designed by the European quality of life group to be
brief, simple and easy to use alongside disease-specific
measures [11]. The health states can be converted to a
single utility value using a formula based on valuation
from a general population sample [12]. Zimbabwe is the
only African country where such population norms are
available [13], and these were used in the present ana-
lysis; a choice justified because Zambia and Zimbabwe
are neighbouring countries with similar cultures.
Cost data collection and analysis
Mean costs per cataract surgery and RE/presbyopia cor-
rection were estimated by adding patient specific and facil-
ity overhead costs. Patient specific transport costs were
collected from interviews, and types and quantities of
drugs were gathered from patient records. Drug unit costs
were obtained from hospital pharmacies. Facility costs
specific to cataract surgery included medical equipment,
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surgical staff and supplies. Sightsavers procured poly-
methylmethacrylate intraocular lenses (IOL) at a unit cost
of US$ 2.63 for Choma and Livingstone. LEH used the
same IOLs, which were procured for US$ 6.00 per lens.
Costs for RE/presbyopia correction included optometrist
equipment, staff time and spectacles.
Since there was a spectacle manufacturing workshop
at LEH, the mean costs of a pair of spectacles were esti-
mated by dividing the total 2010 costs of this workshop
by the annual number of spectacles produced. In Choma
and Livingstone, the intention was that patients should
be given spectacles at a subsidised price of 10,000–
15,000 Kwacha (US$ 2–3), or free for those who could
not afford it. Glasses were purchased by Sightsavers at
US$ 4 per pair, including import duties. However, due to
administrative problems in distributing the spectacles,
some patients had to buy from optical shops. These
costs were collected through interviews.
Costs of spectacles were not included for patients
undergoing cataract surgery as in most African settings
only a small proportion of cataract patients returns for
follow up. Demand for near correction is also low as
most patients are elderly, not literate and do not own or
drive a car. Indeed, uncorrected refractive error is a
common cause of visual impairment following cataract
surgery [14].
Overhead costs were defined as all expenses that did
not vary across patients, but were needed to run the
health facility, such as administrative staff, buildings and
utilities. Separate overhead costs were calculated for
consultations and overnight stay in hospital. Recurrent
costs were collected from 2010 expense records. Present
values and life expectancies of capital costs, including
buildings, vehicles and ophthalmology equipment, were
approximated from procurement lists and by consulting
staff in charge. The values of the Government buildings
were collected from district Buildings Department of-
fices. Capital items were amortised at a discount rate of
3% per year.
For the cost-effectiveness analysis, the mean costs
across the three facilities were weighted according to the
number of study patients recruited from each, to obtain
an average cost for cataract surgery and spectacle
provision. The range of costs between facilities was used
to estimate standard deviations around mean values.
Costs were estimated in 2010 US$ using an exchange
rate of 4,729 Kwacha to one US$.
State-transition modelling
Two cohort state-transition models were developed to
estimate the cost-effectiveness of eye care services com-
pared to ‘no intervention’, expressed as incremental costs
per Quality Adjusted Life Year (QALY) gained. The cata-
ract surgery decision model (Figure 1A) assumed three
health states: Treatment (T), deterioration (D) and death
(M). Simulated patients entered the model at age 63 (the
average age of the study sample) and were followed in an-
nual cycles until death. After undergoing cataract surgery,
all patients enter the T state and experience increased util-
ity compared to baseline. To incorporate the possibility of
ineffective or short-lived effects of surgery, it was assumed
that at the end of each annual cycle, 4% of patients enter
the D state, where baseline utility is experienced until
death [15]. For the comparator cohort (no cataract sur-
gery) all patients start in the D state.
The refraction model had a similar structure (Figure 1B),
but the cohort was modelled from age 39 for five one-year
cycles only. It was assumed that each year a proportion of
patients will lose, break or damage their spectacles, with
the probability increasing exponentially as a function of
time from 5% at the end of the first cycle to 90% at the
end of the five year modelling horizon. Future health ef-
fects were discounted by 3% per year and Zambian life ta-
bles were used to predict the annual probability of dying
from all causes [16,17].
Uncertainty and sensitivity analysis
Parameter uncertainty was incorporated by assigning
probability distributions to costs, utilities and transition
probabilities and running a Monte Carlo simulation with
10,000 iterations. Beta distributions were assigned to
utilities and transition probabilities, and gamma distribu-
tions to costs [18]. The probability of the interventions
being considered cost-effective was expressed as the
probability of the incremental cost-effectiveness ratios
being less than the 2011 Gross National Income (GNI)
per capita in Zambia of US$ 1,160 [19]. This assumption
was based on World Health Organization recommen-
dations that an intervention with costs per Disability Ad-
justed Life Year averted of less than GNI per capita can
be considered highly cost-effective [20]. It must however
be emphasised that the Zambian Government has not
established an official cost-effectiveness threshold.
A sensitivity analysis was undertaken by assuming the
highest mean costs estimated from the three facilities.
Results
Recruitment and follow-up
A total of 170 cataract and 113 RE/presbyopia patients
were recruited at baseline (Figure 2). This was less than
targeted due to irregular outreach services by Living-
stone and Choma Hospitals. Loss to follow-up was 25%
for cataract and 7% for RE/presbyopia patients. Cataract
patients were difficult to follow-up as most were elderly
and did not own a cell phone and, as they were no lon-
ger household heads, they were not known by name in
their community. One patient from LEH was excluded
because he was terminally ill at follow-up.
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At follow-up, 29% of cataract patients had not received
surgery, reasons being long waiting times (22%), being
busy or not available at the time scheduled for surgery
(20%), did not know where to go for surgery (18%), co-
morbidities affecting the risk of surgery (8%), fear (8%),
financial constraints (4%), and other or unclear reasons
(18%). Fifty-seven percent of all patients who had been
prescribed spectacles (49% of refractive errors and 70%
of presbyopia) had not received them, with reasons be-
ing financial constraints (72%), long waiting times for
free spectacles (16%), did not know where to collect
(8%), and a belief that using glasses would damage the
eyes (5%). The total number of patients included in the
analysis was 77 for cataract, 28 for RE and 13 for presby-
opia. Due to the low sample sizes, the RE and presbyobia
patients were combined and we did not conduct separ-
ate analysis for the three facilities.
Patient characteristics
Mean ages were 33, 50 and 63 years for RE, presbyopia
and cataract patients, respectively (Table 1). Sixty two
percent of presbyopia, 39% of RE and 8% of cataract pa-
tients had higher than secondary education. While the
majority of interviews with RE and presbyopia patients
were done in English, most cataract patients spoke local
languages only.
Treatment costs
Mean treatment costs per cataract surgery were US$ 49,
US$ 76 and US$ 111 at Choma, Livingstone and LEH,
respectively, and the costs per RE correction were US$ 21,
US$ 66 and US$ 70 at Choma, Livingstone and LEH, re-
spectively (Table 2). Overhead costs at Choma were lower
than at the two other facilities because of a relatively high
volume of patients in spite of being a small facility. The
total numbers of eye patients seen during 2010 were
17,413 at LEH, 3,039 at Livingstone and 2,682 at Choma.
The mean costs of spectacles were US$ 4 in Choma,
US$ 15 at LEH and US$ 20 at Livingstone. In Choma all
patients received their spectacles from the Sightsavers
project, but in Livingstone five of the twelve patients
bought their spectacles from an optical shop for between
US$ 21 and US$ 106 per pair. At LEH, patients paid be-
tween US$ 12 and US$ 148 for spectacles, depending on
the design, but the mean costs of production at the LEH
manufacturing workshop were US$ 15. Mean, weighted
costs across the three facilities used in the cost-
effectiveness analysis were US$ 92 per cataract surgery
and US$ 72 per RE correction (Table 3).
Transport costs
Mean travel time to the health facility one way was
35 minutes at Livingstone, 64 minutes at Choma and
77 minutes at LEH, ranging from less than 15 minutes
to more than three hours for eight of the patients. At
LEH, 51% used public transport, 45% their own car and
4% walked. At the two rural facilities, 20% used public
transport, 19% their own car, and 61% walked. Transport
costs were thus higher at LEH than at the rural facilities
(Table 2).
Figure 1 Structure of the state-transition models. (A) Cataract (B) Refractive error/presbyopia.
Figure 2 Patient flow in cohort study.
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Visual acuity and utility values
All cataract patients were undergoing surgery to their first
eye. In Zambia second eye surgery is uncommon on
account of costs and low capacity of eye care services.
Record keeping was sub-optimal, particularly at rural facil-
ities, and reliable VA data were only available for 99 (35%)
patients at baseline (52 for cataract, 41 for refractive error,
and 6 for presbyopia), and only for 48 of the 77 cataract
patients traced at follow-up. Mean logMAR VA (standard
deviation) in the better-seeing eye at baseline was 0.24
(0.36) for RE, 0.17 (0.25) for presbyopia and 1.13 (0.72) for
cataract. At first review one week after surgery, the mean
VA of cataract patients was 1.12 (0.75).
There were significant differences in mean EQ-5D util-
ity values between baseline and follow-up for both cata-
ract and RE/presbyopia (Table 4), being 0.05 and 0.075
for cataract and RE, respectively. This level of change is
comparable to impacts found for interventions to treat
diseases such as arthritis and irritable bowel syndrome
[21]. Cataract patients had lower utility values than RE/
presbyopia patients at both baseline and follow-up.
Deterministic and probabilistic cost-effectiveness estimates
In the deterministic analysis, incremental costs per
QALY gained were US$ 259 for cataract surgery and US$
375 for RE/presbyopia correction (Table 5). When ex-
cluding transport costs, the costs per QALY gained were
US$ 231 for cataract surgery and US$ 322 for RE/presby-
opia correction. When using the mean costs of LEH in a
sensitivity analysis, the incremental costs per QALY
gained were US$ 360 for cataract surgery and US$ 458
for RE/presbyopia correction.
The probabilities of the cost-effectiveness ratios being
below the Zambian GNI per capita of US$ 1,160 were
95% for both cataract surgery and RE correction, as
shown in the cost-effectiveness acceptability curves in
Figure 3.
Discussion
To our knowledge, this is the first economic evaluation of
eye care interventions in Africa using primary data for
costs as well as health effects. In the deterministic analysis,
the costs per QALY gained were US$ 259 for cataract sur-
gery and US$ 375 for RE/presbyopia correction.
We also believe that we are the first to elicit utility
values from the Zambian population using a validated in-
strument. Other Zambian cost-effectiveness studies using
Table 1 Patient socio-demographic characteristics
Cataract
(n = 77)
Refractive error
(n = 28)
Presbyopia
(n = 13)
Percent female 48% 64% 62%
Age (years):
15–30 6 (8%) 15 (54%) 1 (8%)
31–50 10 (13%) 10 (36%) 4 (31%)
51–70 33 (43%) 2 (7%) 8 (62%)
70–91 28 (36%) 1 (4%) 0 (0%)
Education
None 16 (21%) 4 (14%) 0 (0%)
Primary 36 (47%) 3 (11%) 0 (0%)
Secondary 19 (25%) 10 (36%) 5 (38%)
Higher 6 (8%) 11 (39%) 8 (62%)
Marital status
Married 47 (61%) 10 (36%) 9 (69%)
Widowed 19 (25%) 1 (4%) 2 (15%)
Divorced 8 (10%) 3 (11%) 0 (0%)
Single 3 (4%) 14 (50%) 2 (15%)
Language of interview
Nyanja 31 (40%) 6 (21%) 1 (8%)
Tonga 29 (38%) 1 (4%) 1 (8%)
English 17 (22%) 21 (75%) 11 (85%)
Table 2 Mean costs per patient of cataract surgery and refractive error correction (2010 US$)
Lusaka eye hospital Choma eye unit Livingstone eye unit
Cataract surgery Refraction Cataract surgery Refraction Cataract surgery Refraction
General overhead 31 31 4 4 30 30
Surgery overhead 21 NA 9 NA NC NA
Diagnosis specific equipment 8 1 2 5 2 12
Diagnosis specific drugs and supplies 33 10 18 0.5 18 0.8
Diagnosis specific staff 18 12 16 7 26 3
Spectacles NA 15 NA 4 NA 20
Subtotal 111 70 49 21 76 66
Transport 17 18 4 1 4 2
Total 128 88 53 22 80 68
NA: Not applicable, NC: not calculated.
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QALYs as an outcome measure have focused on HIV/
AIDS interventions [22-24] and used secondary utility
data, such as from a meta-analysis of HIV utilities in high-
income countries [25]. We showed that EQ-5D was sensi-
tive to significant improvements in HRQOL due to the
two interventions, which is noteworthy as EQ-5D is a gen-
eric instrument, which does not include dimensions spe-
cific to eye health. Previous studies have shown a lack of
sensitivity to HRQOL changes for a range of eye condi-
tions [26,27]. One reason for significant impact being de-
tected in our study could be that patients in Zambia,
similarly to other low-income settings, wait until they are
virtually blind before they seek care [28]. This is not the
case in high-income countries where cataract surgery and
RE/presbyopia correction are provided earlier, so that vis-
ual acuity improvement and hence QALY gains will be
relatively small. Our findings on the positive impact of
cataract surgery on HRQOL in a low-income setting are
consistent with findings from Kenya, the Philippines and
Bangladesh [7].
The EQ-5D instrument used in this study has only
three levels for each dimension. The EQ-5D-5L, which
has five levels, has recently been developed to improve
sensitivity. Evidence suggests that EQ-5D-5L has super-
ior psychometric properties as it reduces the ceiling
effect and has higher discriminatory power in patients
with chronic diseases [29,30]. EQ-5D-5L may, therefore,
capture more accurately the HRQOL benefits of cataract
surgery and correction of REs.
Although evidence from a wide range of settings sug-
gests that cataract surgery is generally cost-effective in
both low- and high-income countries [31], the range in
values is wide, i.e. US$ 1,486 per QALY gained in Japan
[32] versus US$ 25,000 in the United Kingdom [33]. In
a study from Tanzania costs per QALY gained from
cataract surgery were estimated to be US$ 83 [31].
However, cost data in this study were informed by a
willingness-to-pay approach [34] and utility values were
sourced from high-income settings [35,36]. Few studies
report the cost-effectiveness of RE correction. It has
been suggested that screening and spectacles provision
are highly cost-effective for school children [37,38] and
estimates in the adult Australian population over a five-
year horizon were approximately US$ 45 per QALY
gained [39].
The worldwide variation in cost-effectiveness can be
attributed to several factors. Firstly, the costs of cataract
surgery vary. For example, a study of nine European
countries reported costs of cataract surgery to vary from
US$ 32,360 in Spain to $ 59,928 in Denmark, with
Table 3 Parameter values for the state-transition models
Parameter Mean (SE) Distribution Source
Costs (2010 US$)
Cataract surgery 92 (3.4) Gamma Cohort study
Corrective glasses 72 (7.8) Gamma Cohort study
Utility values
Baseline cataract 0.782 (0.017) Beta Cohort study
Six months after cataract surgery 0.832 (0.015) Beta Cohort study
Baseline refractive error 0.850 (0.022) Beta Cohort study
Six months after refractive error correction 0.925 (0.018) Beta Cohort study
Annual transition probabilities
Death - - Zambia life tables
Deterioration after cataract surgery 0.04 (0.01) Beta Lundström and Wendel [15]
Deterioration after spectacles acquirement 0.05 (0.01)* Beta Assumed
*In the first year, then increasing exponentially each cycle so that 90% of the cohort has deteriorated spectacles by the end of the five-year time horizon.
Table 4 EQ-5D utility values at baseline and six months follow-up
Cataract (n = 77) Refraction (n = 41)
Utility value Baseline Follow-up P-value* Baseline Follow-up P-value*
Mean 0.782 0.832 0.014 0.850 0.925 0.006
SD 0.150 0.129 0.139 0.117
Min 0.130 0.417 0.361 0.509
Max 1 1 1 1
*P-value of a t-test for a difference in mean utility values between baseline and follow-up.
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health care labour duration, length of stay, inpatient vs.
outpatient surgery and the type of IOL being the main
cost determinants [40]. Secondly, lifetime estimates vary
because the underlying decision models take markedly
different approaches with respect to the modelled cohort
and clinical pathways. For example, studies in the United
Kingdom estimated the lifetime cost-effectiveness of first
[41] and second-eye [33] cataract surgery by assuming
only two health states (alive and dead) and constant life-
time surgery benefit. An argument can be made that fac-
tors such as the costs and incidence of complications of
cataract surgery, visual acuity decline over time, and the
patient response to visual acuity decline (e.g. immediate,
delayed or no spectacles purchase) can and should also
be taken into account [32,42]. However, implementing
such considerations is always subject to the availability
of data, especially in a context such as Zambia where
few routine data are collected and eye health care ser-
vices remain suboptimal [3].
The crisis in the health workforce in Africa impinged
on our study in Zambia, as this was the primary reason
why only 45% of cataract and 36% of RE/presbyopia pa-
tients received their expected services. Another reason
could be that a proportion of our patients were recruited
during outreach services. To receive cataract surgery or
a spectacles prescription, the patients would have to
travel to the health facility by their own means. During
our follow-up interviews, it was revealed that patients
found this difficult. Outreach services for eye health ser-
vices are thus challenging and it is likely that the costs
of successful provision of services in this manner are
higher than the estimates presented in our study. A third
constraint was the lack of spectacle manufacturing work-
shops outside Lusaka and an ineffective distribution
system, which meant that patients had to wait an unrea-
sonably long time for the spectacles to arrive.
The low uptake of services was a challenge to our cost
estimates. We allocated overhead costs to all patients
who attended the facilities, including those who were
only screened, but did not receive the expected interven-
tions. It can thus be argued that the costs per person
effectively treated are higher than in our estimates, as a
smaller number of patients would have to “share” the
overhead costs. Moreover, establishment of an effective
distribution system for spectacles would likely have in-
creased the costs per pair of glasses. Estimating overhead
costs in the two Government facilities was also difficult,
partly due to non-computerised cost-accounting sys-
tems, but also because eye care constitutes a relatively
small proportion of services, making it complex to deter-
mine what cost categories to include. A further study
limitation was that costs of follow-up and treatment of
complications after cataract surgery were not included.
Since there were no standard procedures in place at the
Table 5 Cost-effectiveness results (per patient over modelling horizon)
Cataract Refractive error
Without surgery With Surgery Incremental Without spectacles With spectacles Incremental
Deterministic analysis
Costs (2010 US$) 0 92 92 0 72 72
QALYs 7.519 7.874 0.355 3.655 3.847 0.192
Incremental costs per QALY gained 259 375
Probabilistic analysis
Costs (2010 US$) 0 92 92 0 71 71
QALYs 7.519 7.876 0.356 3.654 3.750 0.096
Incremental costs per QALY gained 258 748
Figure 3 Cost-effectiveness acceptability curves derived from probabilistic uncertainty analysis.
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three facilities for patient follow-up, it was problematic
to assess this cost. We do however recommend that fu-
ture studies on the costs of cataract surgery make deter-
mined efforts to include this.
According to accepted international benchmarks, cata-
ract surgery and RE/presbyopia correction can be con-
sidered highly cost-effective in Zambia [20]. However,
severe health system and human resource constraints
make it difficult to scale up services.
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